Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Designing the Future
0
Zitationen
4
Autoren
2026
Jahr
Abstract
Artificial Intelligence (AI) is transforming drug delivery and discovery, promising faster timelines, enhanced efficacy, and personalized treatments. AI has achieved significant advancements in cancer detection, cardiovascular theranostics, and bioinformatics. Machine learning algorithms expedite drug candidate identification by predicting efficacy and safety, streamlining drug development, and enabling precision therapies. AI-driven models also design nanoscale delivery systems for targeted drug release, minimizing side effects and maximizing efficacy. In personalized medicine, AI analyzes genomics, proteomics, and clinical data to identify biomarkers, predict treatment responses, and optimize therapeutic regimens, shifting from one-size-fits-all to tailored interventions based on individual genetic profiles.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.551 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.443 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.942 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.792 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.